Human nuclear genome transfer (So-called mitochondrial replacement): Clearing the underbrush

Bioethics

Volumn 31, Issue 1, 2017, Pages 7-19

  Baylis, Françoise ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Common good; Mitochondrial disease; Mitochondrial replacement; Need; Nuclear genome transfer; Social justice; Want

Indexed keywords

MITOCHONDRIAL DNA;

CELL NUCLEUS TRANSPLANTATION; CLONING; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ETHICS; FEMALE; GENETICS; HUMAN; MITOCHONDRION;

CLONING, ORGANISM; DNA, MITOCHONDRIAL; FEMALE; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; NUCLEAR TRANSFER TECHNIQUES;

EID: 85010912655     PISSN: 02699702     EISSN: 14678519     Source Type: Journal    
DOI: 10.1111/bioe.12309     Document Type: Article

References (80)

1. M.H. Shapiro. Is Bioethics Broke? On the Idea of Ethics and Law ‘Catching Up’ with Technology. Indiana. Law Rev 1999; 33: 17-162: 30.
2. National Academies of Sciences, Engineering, and Medicine. 2016. Mitochondrial Replacement Techniques: Ethical, Social, and Policy Considerations. Washington, DC: The National Academies Press. Available at: http://www.nap.edu/catalog/21871/mitochondrialreplacement-techniques-ethical-social-and-policy-considerations [Accessed 27 Jun 2016].
3. Nuffield Council on Bioethics. 2012. Novel Techniques for the Prevention of Mitochondrial DNA Disorders: An Ethical Review. London, UK: Nuffield Council on Bioethics. Available at: http://www.nuffieldbioethics.org/sites/default/files/Novel_techniques_for_the_prevention_of_ mitochondrial_DNA_diseases_compressed.pdf/[Accessed 9 Sept 2016].
4. F. Baylis, N. Kenny, & S. Sherwin. A Relational Account of Public HealThethics. Public HealThethics 2008; 1(3): 196-209: 196.
5. P. Amato, M. Tachibana, M. Sparman, & S. Mitalipov. Three-Parent IVF: Gene Replacement for the Prevention of Inherited Mitochondrial Diseases. Fertil Steril 2014; 101(1): 31-35.
6. R.W. Taylor & D. Turnbull. Mitochondrial DNA Mutations in Human Disease. Nat Rev Genet 2005; 6(5): 389-402
7. S. Di Mauro. Mitochondrial DNA Mutation Load: Chance or Destiny? JAMA Neurology 2013; 70(12): 1484-1485.
8. S. Dimauro & G. Davidzon. Mitochondrial DNA and Disease. Annals of Medicine 2005; 37(3): 222-232: 222.
9. L. Craven, J.L. Elsom, L. Irving, S.J. Harbottle, J.L. Murphy, L.M. Cree et al. Turnbull. MitochondrialDNA Disease: New Options for Prevention. Hum Mol Genet 2011; 20(R2): R168-R174.
10. M. Tachibana, M. Sparman, H. Sritanaudomchai, H. Ma, L. Clepper, J. Woodward et al. Mitochondrial Gene Replacement in Primate Offspring and Embryonic Stem Cells. Nature 2009; 461: 367-372
11. L. Craven, H.A. Tuppen, G.D. Greggains, S.J. Harbottle, J.L. Murphy, L.M. Cree et al. Pronuclear Transfer in Human Embryos to Prevent Transmission of MitochondrialDNA Disease. Nature 2010; 465: 82-85.
12. J. Zhang, G. Zhuang, Y. Zeng, C. Acosta, Y. Shu, & J. Grifo. Pregnancy Derived From Human Pronuclear Transfer. Fertil Steril 2003; 80 (Suppl 3): S56 (Abstract # O-148).
13. J. Zhang, G. Zhuang, Y. Zeng, J. Grifo, C. Acosta, Y. Shu, & H. Liu. Pregnancy Derived from Human Zygote Pronuclear Transfer in a Patient Who Had Arrested Embryos After IVF. Reprod BioMed Online 2016; 33(4):529-533.
14. United Kingdom Government. 2015. The Human Fertilisation and Embryology (Mitochondrial Donation) Regulations 2015 No. 572. London, UK: The National Archives. Available at: http://www.legislation.gov.uk/ukdsi/2015/9780111125816/contents [Accessed 8 Sept 2016].
15. F. Baylis. The Ethics of Creating Children with Three Genetic Parents. Reprod Biomed Online 2013; 26(6): 531-534.
16. T. Rulli. What is the Value of Three-Parent IVF? Hastings Cent Rep 2016; 46(4): 38-47.
17. M. Yamada, V. Emmanuele, M.J. Sanchez-Quintero, B. Sun, G. Lallos, D. Paull et al. Genetic Drift Can Compromise Mitochondrial Replacement by Nuclear Transfer in Human Oocytes. Cell Stem Cell 2016; 18(6): 749-754.
18. D. Egli interviewed by P. Knoepfler. 9 Jun 2016. Mitochondrial Replacement Hype Goes Nuclear Including by Wellcome Trust. The Niche: Knoepfler Lab Stem Cell Blog. Available at: http://www.ipscell. com/2016/06/mitochondrial-replacement-hype-goes-nuclear-includingby-wellcome-trust/[Accessed 8 Sept 2016].
19. L.A. Hyslop, P. Blakeley, L. Craven, J. Richardson, N.M. Fogarty, E. Fragouli et al. Towards Clinical Application of Pronuclear Transfer to Prevent MitochondrialDNA Disease. Nature 2016; 534(7607): 383-386.
20. P. Knoepfler. 8 Jun 2016. New Herbert Lab Nature Paper Reinforces Mitochondrial Replacement Achilles Heel. The Niche: Knoepfler Lab Stem Cell Blog. Available at: https://www.ipscell.com/2016/06/newnature-paper-reinforces-that-mitochondrial-replacement-has-achilles-heel/#more-19470 [Accessed 27 Jun 2016].
21. Science Outpacing Ethical Studies in Genetics. Can Med Assoc J 1978; 119(1): 78-80
22. N. Wosnick. 10 May 2012. As ourDNA Defines Us, Science Outpaces Ethics. Globe & Mail. Available at: http://www.theglobeandmail. com/opinion/as-our-dna-defines-us-science-outpaces-ethics/article4105699/[Accessed 27 Jun 2016].
23. M.A. Rothstein. Science and Society: Applications of Behavioural Genetics: Outpacing the Science? Nat Rev Genet 2005; 6(10): 793-798.
24. D. Orentlicher. The Misperception that Bioethics and the Law Lag Behind Advances in Biotechnology: A Response to Michael H. Shapiro. Indiana Law Rev 1999; 33(1): 163-172: 164.
25. D.S. Rubenstein, D.C. Thomasma, E.A. Schon, & M.J. Zinaman. Germ-line Therapy to Cure Mitochondrial Disease: Protocol and Ethics of In Vitro Ovum Nuclear Transplantation. Camb Q Healthc Ethics 1995; 4(3): 316-339
26. M.D. Bacchetta & G. Richter. Response to ‘Germline Therapy to Cure Mitochondrial Disease: Protocol and Ethics of In Vitro Ovum Nuclear Transplantation’ by D.S. Rubenstein, D.C.
27. Thomasma, E.A. Schon, & M.J. Zinaman (CQ Vol.4, No.3). Camb Q Healthc Ethics 1996; 5(3): 450-457.
28. A.L. Bonnicksen. Transplanting Nuclei Between Human Eggs: Implications for Germ-Line Genetics. Politics the Life Sci 1998; 17(1): 3-10
29. J.A. Robertson. Oocyte Cytoplasm Transfer and the Ethics of Germline Interventions. J Law Med Ethics 1998; 26(3): 211-220.
30. J. Cohen, R. Scott, T. Schimmel, J. Levron, & S. Willadsen. Birth of Infant After Transfer of Anucleate Donor Oocyte Cytoplasm Into Recipient Eggs. Lancet 1997; 350(9072): 186-187.
31. J.A. Barritt, C.A. Brenner, H.E. Malter, & J. Cohen. Mitochondria in Human Offspring Derived From Ooplasmic Transplantation. Hum Reprod 2001; 16(3): 513-516.
32. F. Baylis. ‘Babies with Some Animal DNA in Them’: AWoman’s Choice? Int J Fem Approaches Bioeth 2009; 2(2): 75-96.
33. R.K. Naviaux & K.K. Singh. Need for Public Debate About Fertility Treatments. Nature 2001; 413(6854): 347
34. E. Parens & E. Juengst. Inadvertently Crossing the Germ Line. Science 2001; 292(5516): 397
35. A. Templeton. Ooplasmic Transfer—Proceed with Care. N Engl J Med 2002; 346: 773-775.
36. HFEA Grants Licence to Newcastle Centre at LIFE for Mitochondrial Research. 8 Sept 2015. London, UK: Human Fertilisation & Embryology Authority. Available at: http://www.hfea.gov.uk/671.html [Accessed 27 Jun 2016].
37. A. Bredenoord & P. Braude. Ethics of Mitochondrial Gene Replacement: From Bench to Bedside. Br Med J 2011; 342: 87-89
38. A. Bredenoord, W. Dondorp, G. Pennings, G. deWert. Ethics of Modifying the Mitochondrial Genome. J Med Ethics 2011; 37: 97-100
39. J.B. Appleby. The Ethical Challenges of the Clinical Introduction of Mitochondrial Replacement Techniques. Med Health Care Philos 2015; 189(4): 501-514.
40. Newcastle Fertility Centre. 2016. Mitochondrial Transmission. Newcastle, UK: Newcastle upon Tyne Hospitals, NHS Foundation Trust. Available at: http://www.newcastle-hospitals.org.uk/services/fertilitycentre_ research-and-technology_mitochondrial-transmission.aspx [Accessed 27 Jun 2016].
41. D.P. Wolf, N. Mitalipov, & S. Mitalipov. Mitochondrial Replacement Therapy in Reproductive Medicine. Trends Mol Med 2015; 21(2): 68-76: 75.
42. Food and Drug Administration. 25-26 Feb 2014. Briefing document, Cellular, Tissue, and Gene Therapies Advisory Committee. Meeting #59 Oocyte Modification in Assisted Reproduction for the Prevention of Transmission of Mitochondrial Disease or Treatment of Infertility. Available at: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeeting Materials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM385461.pdf [Accessed 27 Jun 2016].
43. Human Fertilisation & Embryology Authority. Code of Practice, 8Thedition. Oct 2015. London, UK: Human Fertilisation & Embryology Authority. Available at: http://www.hfea.gov.uk/docs/HFEA_Code_of_ Practice:8th_Edtion_(Oct_2015).pdf [Accessed 27 Jun 2016].
44. D. Jones. The Other Woman: Evaluating the Language of _Three Parent_ Embryos. Clin Ethics 2015; 10(4): 97-106.
45. E. Haimes & K. Taylor. Rendered Invisible? The Absent Presence of Egg Providers in U.K. Debates on the Acceptability of Research and Therapy for Mitochondrial Disease. Monash Bioeth Rev 2015; 33(4): 360-378: 364-365.
46. J. Nisker. The Latest Thorn by Any Other Name: Germ-Line Nuclear Transfer in the Name of ‘Mitochondrial Replacement’. J Obstet Gynaecol Can 2015; 37(9): 829-831: 829.
47. J. Nisker. The Latest Thorn by Any Other Name: Germ-Line Nuclear Transfer in the Name of ‘Mitochondrial Replacement’. J Obstet Gynaecol Can 2015; 37(9): 830.
48. F. Baylis & J.S. Robert. 2005. Radical Rupture: Exploring Biological Sequelae of Volitional Inheritable Genetic Modification. In J.E.J. Rasko, G.M. O’Sullivan, & R.A. Ankeny, eds. The Ethics of Inheritable Genetic Modification. Cambridge: Cambridge University Press: 131-148.
49. The Truth about Mitochondrial Replacement. Impact Ethics. Available at: http://impactethics. ca/2015/02/23/the-truth-about-mitochondrial-replacement/[Accessed 27 Jun 2016]
50. F. Baylis. 2 Jul 2013. Ethical Objections to Mitochondrial Replacement. Impact Ethics. Available at: http://impactethics.ca/2013/07/02/ethical-objections-to-mitochondrial-replacement/[Accessed 27 Jun 2016].
51. S. Kirkey. 23 Dec 2015. Three-parent Babies: How the Future of FertilityWill Challenge Ideas of Parenthood. National Post. Available at: http://news.nationalpost.com/news/canada/three-parent-babies [Accessed 27 Jun 2016].
52. M.J. Adler. 1978. Aristotle for Everybody. NewYork: Macmillan Publishing: 85.
53. S. Holm. The Medicalization of Reproduction-A 30 Year Retrospective. In F. Simonstein, ed. 2009. Reprogen-Ethics and the Future of Gender. Published online by Springer as International Library of Ethics, Law, and the New Medicine 2009; 43: 29-36. Available at: http://link.springer. com/book/10.1007%2F978-90-481-2475-6 [Accessed 9 Sept 2016].
54. M.D. Bayles. 1984. Reproductive Ethics. Englewood Cliffs, NJ: Prentice Hall: 13.
55. S. Franklin. 1990. Deconstructing ‘Desperateness’: The Social Construction of Infertility in Popular Representations of New Reproductive Technologies. In M. McNeil, I. Varco, & S. Yearley, eds. The New Reproductive Technologies. London, UK: Palgrave Macmillan UK: 200-229: 207.
56. R.G. Edwards & D.J. Sharpe. Social Values and Research in Human Embryology. Nature 1971; 231(5298): 87-91: 87.
57. D.E. Roberts. The Genetic Tie. Univ Chic Law Rev 1995; 62(1): 209-273: 215.
58. J.D. Velleman. Family History. Philosophical Papers 2005; 34(3): 357-378
59. J.D. Velleman. Persons in Prospect. Philos Public Aff2008; 36(3): 221-288.
60. C. Witt. 2014. ACritique of the Bionormative Concept of the Family. In F. Baylis & C. McLeod, eds. Family-Making: Contemporary Ethical Challenges. Oxford: Oxford University Press: 49-63.
61. T. Rulli. Preferring a Genetically-Related Child. J Moral Philos Nov 2014; DOI: 10.1163/17455243-4681062: 1-30. Available at: http://trulli. faculty.ucdavis.edu/wp-content/uploads/sites/86/2014/07/17455243_46 81062_text.pdf [Accessed 9 Sept 2016].
62. C. McLeod & A. Botterell. ‘Not for the Faint of Heart’: Assessing the Status Quo on Adoption and Parental Licensing. In Baylis & McLeod, eds., note 74.
63. A. Greenfield— Review panel chair. Jun 2014. Third Scientific Review of the Safety and Efficacy of Methods to Avoid Mitochondrial Disease through Assisted Conception: 2014 Update. London, UK: Human Fertilisation & Embryology Authority. Available at: http://www.hfea.gov. uk/docs/Third_Mitochondrial_replacement_scientific_review.pdf [Accessed 27 Jun 2016]
64. J. Richardson, L. Irving, L.A. Hyslop, M. Choudhary, A. Murdoch, D. Turnbull, & M. Herbert. Concise Reviews: Assisted Reproductive Technologies to Prevent Transmission of Mitochondrial DNA Disease. Stem Cells 2015; 33(3): 639-645.
65. G.S. Gorman, J.P. Grady, Y. Ng, A.M. Schaefer, R.J. McNally, P.F. Chinnery et al. Mitochondrial Donation-How Many Women Could Benefit? N Engl J Med 2015; 372(9): 885-887.
66. H. Turnbull, R. Say, M. Smith, V. Nesbitt, R. McFarland, D. Turnbull, & M. Schaefer—The Guideline Development Group. Jun 2011. Newcastle Mitochondrial Disease Guidelines: Pregnancy in Mitochondrial Disease. Available at: http://www.mitochondrialncg.nhs.uk/documents/Pregnancy_Guidelines_%202011.pdf [Accessed 27 Jun 2016].
67. E.Y. Adashi & L.A. Dean. Access to and Use of Infertility Services in the United States: Framing the Challenges. Fertil Steril 2016; 105(5): 1113-1118.
68. R.E. Say, R.G. Whittaker, H.E. Turnbull, R. McFarland, R.W. Taylor, & D.M. Turnbull. Mitochondrial Disease in Pregnancy: A Systematic Review. Obstet Med 2011; 4(3): 90-94.
69. University College London. 2016. Incidence of Complications of Pregnancy in Patients Diagnosed with Mitochondrial Disease or Carrying a Mitochondrial DNA Mutation. London, UK: Queen Square for Neuromuscular Diseases. Available at: http://www.cnmd.ac.uk/research/clinical_ trial/incidence-of-complications-of-pregnancy-in-patients-diagnosed-with-mitochondrial-disease-or-carrying-a-mitochondrialdna-mutation [Accessed 9 Sept 2016].
70. American Society for Reproductive Medicine. Fact Sheet: Side Effects of Injectable Fertility Drugs (Gonadotropins). Available at: http://www.reproductivefacts.org/uploadedFiles/ASRM_Content/Resources/Patient_Resources/Fact_Sheets_and_Info_Booklets/Gonadatrophins-Fact. pdf [Accessed 16 Nov 2016].
71. The ESHRE Capri Workshop Group. Social Determinants of HumanReproduction. Hum Reprod 2001; 16(7): 1518-1526.
72. J. Boivin, L. Bunting, J.A. Collins, & K. Nygren. International Estimates of Infertility Prevalence and Treatment-Seeking: Potential Need and Demand for Infertility Medical Care. Hum Reprod 2007; 22(6): 1506-1512.
73. A. Chandra, C.E. Copen, & E.H. Stephen. Infertility Service Use in the United States: Data from the National Survey of Family Growth, 1982-2010. National Health Statistics Report 22 Jan 2014; 73: 1-21.
74. Human Fertilisation & Embryology Authority. 2013. Fertility Treatment in 2013: Trends and Figures. London, UK: Human Fertilisation & Embryology Authority: 17. Available at: http://www.hfea.gov.uk/docs/HFEA_Fertility_Trends_and_Figures_2013.pdf [Accessed 9 Sept 2016].
75. Centers for Disease Control and Prevention. 2013 Assisted Reproductive Technology Fertility Clinic Success Rates Report. 2015. Available at: ftp://ftp.cdc.gov/pub/Publications/art/ART-2013-Clinic-Report-Full.pdf [Accessed 27 Jun 2016].
76. G. Kolata. 19 Aug 1997. Scientists Face New Ethics Quandaries in Baby-Making. New York Times. Available at: http://www.nytimes. com/1997/08/19/science/scientists-face-new-ethical-quandaries-in-babymaking. html?pagewanted5all [Accessed 27 Jun 2016].
77. S. Connor. 7 Feb 2015. Scientist Who Pioneered ‘Three-parent’ IVF Embryo Technique NowWants to Offer it to OlderWomen Trying for a Baby. Independent. Available at: http://www.independent.co.uk/news/science/three-parent-embryos-an-ivf-revolution-or-a-slippery-slope-todesigner-babies-10031477.html [Accessed 9 Sept 2016].
78. S. Wilkinson. 2 Feb 2014. Mitochondrial Replacement Therapy: Ethics and Identity. Presentation: Ottawa,ON.
79. T.N. Reider. 12 Sept 2016. Why we should have fewer children: to save the planet. The Guardian. Available at: https://www.theguardian.com/commentisfree/2016/sep/12/why-we-should-have-fewer-children-savethe-planet-climate-change [Accessed 14 Sept 2016].
80. T.N. Redier. 2016. Toward a Small Family Ethic: How Overpopulation and Climate Change Are Affecting the Morality of Procreation. Springer.